fexofenadine has been researched along with pseudoephedrine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Castellano, PM; Kaufman, TS; Maggio, RM; Vignaduzzo, SE | 1 |
| Karakuş, S; Küçükgüzel, I; Küçükgüzel, SG | 1 |
| Atia, NN; El-Gizawy, SM; El-Kommos, ME; Hosny, NM | 1 |
| Sawatsubashi, M | 1 |
| Fukai, K; Kusutani, N; Maekawa, N; Nishida, M; Sowa-Osako, J | 1 |
| Fromm, MF; Hoier, E; König, J; Misaka, S; Ogata, H; Ono, T; Ono, Y; Shimomura, K; Taudte, RV; Watanabe, H | 1 |
2 review(s) available for fexofenadine and pseudoephedrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Clinical Management of Japanese Cedar Pollinosis].
Topics: Administration, Inhalation; Cedrus; Desensitization, Immunologic; Disorders of Excessive Somnolence; Drug Combinations; Environmental Exposure; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Humans; Nasal Obstruction; Nonprescription Drugs; Patient Satisfaction; Pollen; Practice Guidelines as Topic; Pseudoephedrine; Rhinitis, Allergic, Seasonal; Seasons; Surveys and Questionnaires; Terfenadine | 2016 |
1 trial(s) available for fexofenadine and pseudoephedrine
| Article | Year |
|---|---|
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers.
Topics: Antioxidants; Catechin; Cross-Over Studies; Healthy Volunteers; HEK293 Cells; Humans; Pharmaceutical Preparations; Plant Extracts; Pseudoephedrine; Tea; Terfenadine | 2022 |
4 other study(ies) available for fexofenadine and pseudoephedrine
| Article | Year |
|---|---|
Alternative and improved method for the simultaneous determination of fexofenadine and pseudoephedrine in their combined tablet formulation.
Topics: Calibration; Chromatography, High Pressure Liquid; Drug Combinations; Histamine H1 Antagonists, Non-Sedating; Least-Squares Analysis; Molecular Structure; Nasal Decongestants; Pseudoephedrine; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets; Terfenadine; Time Factors | 2007 |
Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
Topics: Cetirizine; Chromatography, High Pressure Liquid; Dosage Forms; Histamine H1 Antagonists; Pharmaceutical Preparations; Pseudoephedrine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Terfenadine | 2008 |
Thin layer chromatography-densitometric determination of some non-sedating antihistamines in combination with pseudoephedrine or acetaminophen in synthetic mixtures and in pharmaceutical formulations.
Topics: Acetaminophen; Chromatography, Thin Layer; Densitometry; Histamine H1 Antagonists, Non-Sedating; Limit of Detection; Linear Models; Loratadine; Pseudoephedrine; Reproducibility of Results; Tablets; Terfenadine | 2014 |
Acute generalized exanthematous pustulosis induced by pseudoephedrine in a combination tablet with fexofenadine.
Topics: Acute Generalized Exanthematous Pustulosis; Humans; Pseudoephedrine; Tablets; Terfenadine | 2021 |